TRY 10.0
(-2.34%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Operating Cash Flow | 3.17 Billion | 3.08 Billion | -131.69 Million | 1.2 Billion |
Net Income | 1.26 Billion | -784.88 Million | 1.48 Billion | 233.51 Million |
Depreciation & Amortization | 5.33 Billion | 2.17 Billion | 1.29 Billion | 679.96 Million |
Deferred income taxes | -402.98 Million | 532.38 Million | -596.93 Million | -149.74 Million |
Stock-based compensation | - | - | - | - |
Change in working capital | -18.43 Million | 41.83 Million | -880.9 Million | 689.47 Million |
Other non-cash items | -3.39 Billion | 6.51 Billion | 1.45 Billion | 785.4 Million |
Investing Cash Flow | 496.58 Million | -1.26 Billion | -847.25 Million | -1.38 Billion |
Investments in PPE | -82.21 Million | -1.38 Billion | -947.04 Million | -1.39 Billion |
Acquisitions | 27.35 Thousand | 113.85 Million | 11.22 Million | 5.72 Million |
Investment purchases | - | - | - | - |
Sales/Maturities of investments | - | - | 88.57 Million | - |
Other Investing Activities | 578.79 Million | 211.28 Million | 1.33 Billion | -1.38 Billion |
Financing Cash Flow | -5.81 Billion | -1.59 Billion | 1.74 Billion | -391.57 Million |
Debt repayment | -4.26 Billion | -1.59 Billion | -483.96 Million | -391.57 Million |
Dividends payments | - | - | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | - | - | 2.22 Billion | - |
Other Financing Activities | -1.55 Billion | -3.33 Billion | -642.35 Million | -1.03 Billion |
Accounts receivables | 1.36 Billion | -1.66 Billion | -421.57 Million | 289 Million |
Accounts payables | -1.08 Billion | 734 Million | 285.97 Million | 33.79 Million |
Inventory | 175.47 Million | -109.72 Million | -168.81 Million | -87.25 Thousand |
Other working capital | -1.56 Billion | 1.08 Billion | -576.48 Million | 366.76 Million |
Cash at beginning of period | 4.15 Billion | 1.53 Billion | 818.4 Million | 993.07 Million |
Cash at end of period | 2 Billion | 2.51 Billion | 1.53 Billion | 818.4 Million |
Capital Expenditure | -82.21 Million | -1.38 Billion | -947.04 Million | -1.39 Billion |
Effect of forex changes on cash | - | 763.16 Million | -45.58 Million | 401.43 Million |
Net cash flow / Change in cash | -2.14 Billion | 983.27 Million | 718.14 Million | -174.66 Million |
Free Cash Flow | 3.09 Billion | 1.7 Billion | -1.07 Billion | -190.25 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -2.03 Billion | -1.67 Billion | 1.26 Billion | 466.83 Million | -84.99 Million | 2.14 Billion |
Depreciation & Amortization | 1.74 Billion | 1.47 Billion | 5.33 Billion | 3.25 Billion | 1.81 Billion | 1.46 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 2.1 Billion | -276.74 Million | -18.43 Million | -18.43 Million | -237.72 Million | -1.26 Billion |
Other non-cash items | 1.77 Billion | -4.34 Billion | -3.39 Billion | -3.37 Billion | 1.05 Billion | -4.59 Billion |
Investing Cash Flow | 111.34 Million | 168.13 Million | 496.58 Million | 106.64 Million | 36.97 Million | -18.8 Million |
Investments in PPE | -21.75 Million | -10.07 Million | -82.21 Million | -82.21 Million | -5.11 Million | -21.84 Million |
Acquisitions | -1.63 Million | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 134.72 Million | 177.93 Million | 578.79 Million | 188.85 Million | 42.08 Million | 2.25 Million |
Financing Cash Flow | -1.3 Billion | -923.2 Million | -5.81 Billion | -1 Billion | -1.96 Billion | -1.78 Billion |
Debt repayment | -1.32 Billion | -2.16 Billion | -4.26 Billion | - | -883.49 Million | -1.58 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 2.33 Billion | - | - | - | - |
Other Financing Activities | 21.45 Million | 1.24 Billion | -1.55 Billion | -1 Billion | -1.08 Billion | 10.45 Million |
Accounts receivables | 189.84 Million | 370.17 Million | 1.36 Billion | 1.36 Billion | 1.01 Billion | -421.69 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | 18.38 Million | 42.72 Million | 175.47 Million | 175.47 Million | 126.96 Million | 41.89 Million |
Other working capital | 1.89 Billion | -624.38 Million | -1.56 Billion | -1.56 Billion | -1.37 Billion | -193.25 Million |
Cash at beginning of period | 2.59 Billion | 2.31 Billion | 4.15 Billion | 2.58 Billion | 3.01 Billion | 4.77 Billion |
Cash at end of period | 4.68 Billion | 2.59 Billion | 2 Billion | 2 Billion | 3.45 Billion | 3.01 Billion |
Capital Expenditure | -21.75 Million | -10.07 Million | -82.21 Million | -82.21 Million | -5.11 Million | -21.84 Million |
Effect of forex changes on cash | -7265.00 | - | - | - | - | - |
Net cash flow / Change in cash | 2.09 Billion | 283.23 Million | -2.14 Billion | -578.16 Million | 443.48 Million | -1.76 Billion |
Free Cash Flow | 3.56 Billion | 1.02 Billion | 3.09 Billion | 242.04 Million | 2.53 Billion | 21.89 Million |
VANTABIO
ALMOU
DEEPAKCHEM
CUBEXTUB
ZWELCAST
ICDSLTD